122 related articles for article (PubMed ID: 2574727)
1. Clinical pharmacology of dilevalol (III). A pharmacokinetic study of dilevalol in elderly subjects with essential hypertension.
Fujimura A; Sugimoto K; Kumagai Y; Nakashima H; Ebihara A
J Clin Pharmacol; 1989 Nov; 29(11):1008-12. PubMed ID: 2574727
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacology of dilevalol (I). Comparison of the pharmacokinetic and pharmacodynamic properties of dilevalol and labetalol after a single oral administration in healthy subjects.
Fujimura A; Ohashi K; Tsuru M; Ebihara A; Kondo K
J Clin Pharmacol; 1989 Jul; 29(7):635-42. PubMed ID: 2668352
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacology of dilevalol (II). The pharmacokinetic, pharmacodynamic, and tolerance studies of dilevalol during repeated administration in healthy subjects.
Fujimura A; Ohashi K; Tsuru M; Ebihara A; Kondo K
J Clin Pharmacol; 1989 Jul; 29(7):643-9. PubMed ID: 2760257
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacology of dilevalol (i.v.). Influence of hepatic and renal functions on the disposition of dilevalol and atenolol in hypertensive subjects.
Kotegawa T; Fujimura A; Ebihara A
J Clin Pharmacol; 1990 May; 30(5):404-8. PubMed ID: 2347954
[TBL] [Abstract][Full Text] [Related]
5. Secretion of dilevalol in breast milk.
Radwanski E; Nagabhushan N; Affrime MB; Perentesis G; Symchowicz S; Patrick JE
J Clin Pharmacol; 1988 May; 28(5):448-53. PubMed ID: 2899094
[TBL] [Abstract][Full Text] [Related]
6. Effects of dilevalol, an R, R-isomer of labetalol, on blood pressure and renal function in patients with mild-to-moderate essential hypertension.
Baba T; Murabayashi S; Aoyagi K; Ishizaki T
Eur J Clin Pharmacol; 1988; 35(1):9-15. PubMed ID: 2905992
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacokinetics and kinetic-dynamic relationships of dilevalol and labetalol.
Donnelly R; Macphee GJ
Clin Pharmacokinet; 1991 Aug; 21(2):95-109. PubMed ID: 1884570
[TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics of dilevalol in renal impairment.
Kelly JG; Laher MS; Donohue J; Doyle GD
J Hum Hypertens; 1990 Jun; 4 Suppl 2():59-62. PubMed ID: 2370645
[TBL] [Abstract][Full Text] [Related]
9. Dilevalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension.
Chrisp P; Goa KL
Drugs; 1990 Feb; 39(2):234-63. PubMed ID: 2184002
[TBL] [Abstract][Full Text] [Related]
10. A multicenter double-blind study of the efficacy and safety of once and twice daily dilevalol compared to propranolol.
Schoenberger JA; Wallin JD; Gorwit JI; Davidov ME; Michelson EL; Poland MP; Frishman WH
Am J Hypertens; 1989 Nov; 2(11 Pt 1):840-6. PubMed ID: 2686711
[TBL] [Abstract][Full Text] [Related]
11. The renal function and blood pressure effects of dilevalol in the normotensive and hypertensive elderly.
Clifton GG; Cook ME; Poland M; Wallin JD
J Clin Pharmacol; 1989 Jul; 29(7):603-8. PubMed ID: 2760254
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the efficacy and safety of dilevalol in the treatment of essential arterial hypertension].
Bochicchio T; Pérez-Grovas HA; Carrizosa J; Herrera-Acosta J
Arch Inst Cardiol Mex; 1989; 59(2):181-6. PubMed ID: 2569857
[TBL] [Abstract][Full Text] [Related]
13. The effects of age on the pharmacokinetics, antihypertensive efficacy and general tolerability of dilevalol.
Macphee GJ; Howie CA; Meredith PA; Elliott HL
Br J Clin Pharmacol; 1991 Nov; 32(5):591-7. PubMed ID: 1954075
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of dilevalol.
Tenero DM; Bottorff MB; Given BD; Kramer WG; Affrime MB; Patrick JE; Lalonde RL
Clin Pharmacol Ther; 1989 Dec; 46(6):648-56. PubMed ID: 2598569
[TBL] [Abstract][Full Text] [Related]
15. Dilevalol: an overview of its clinical pharmacology and therapeutic use in hypertension.
Lalonde RL; Tenero DM; Kazierad DJ
Pharmacotherapy; 1990; 10(1):15-28. PubMed ID: 2179899
[TBL] [Abstract][Full Text] [Related]
16. Effects of dilevalol on forearm circulation in essential hypertension.
Giannattasio C; Cleroux J; Seravalle G; Grassi G; Mancia G; Zanchetti A
Am J Cardiol; 1989 Jun; 63(19):21I-24I. PubMed ID: 2567111
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
18. The influence of age on the pharmacokinetics and antihypertensive responses to dilevalol.
Elliott HL; Macphee GJ; Meredith PA
J Hum Hypertens; 1990 Jun; 4 Suppl 2():45-8. PubMed ID: 2370643
[TBL] [Abstract][Full Text] [Related]
19. High-performance liquid chromatographic assay for dilevalol in human plasma and urine using a PRP-1 column and fluorimetric detection.
Alton KB; Petruzzi RF; Patrick JE
J Chromatogr; 1988 Mar; 425(2):363-72. PubMed ID: 2897376
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive effect of dilevalol is directly related to dose and plasma concentrations.
Given BD; Perentesis G; Christopher JD; Herron J; Patrick JE; Kramer WG; Affrime MB
Am J Cardiol; 1989 Jun; 63(19):12I-16I. PubMed ID: 2729123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
